Skip to content

Gubra wins EY Entrepreneur of the Year

HØRSHOLM, Denmark – October 30, 2019

Tuesday evening at Ledreborg Castle took a sweeping turn upwards for Jacob Jelsing and Niels Vrang when they proudly stepped up at the podium to receive this year’s title and prize as EY Entrepreneur of the Year, Region Zealand.

Celebrates growth, values, leadership and social engagement

The contest and title EY Entrepreneur of the Year celebrates companies’ ability to grow economically as well as their capacity to grow and thrive on values, leadership, and social engagement. In total, 301 companies from Zealand met the requirements that give access to the competition. Gubra won ahead of five other strong companies that were shortlisted for the title which is the biggest prize in the competition.

“The jury is impressed by the company’s excellent results, which has also meant that the number of employees has doubled over the past year. This is largely a global business with sales to the United States and large parts of Europe and collaboration with some of the world’s leading pharma companies. It’s well done in a short time,” says Anders Flymer-Dindler, head of EY Entrepreneur of the Year in Zealand.

With this regional victory as EY Entrepreneur of the Year, Region Zealand, we are all set for the country finals taking place on 28 November. Last year we participated in the same finals under the category Innovation.




Sofia Pitt Boserup

Lead Communication Partner
+45 41889586
[email protected]


About Gubra

Gubra is a privately held biotech company since 2008, headquartered in Denmark. The company is a science and technology driven company with two primary areas of business: Preclinical contract research services (CRO) and proprietary early target and drug discovery programs. Gubra’s primary focus is within the metabolic space (obesity, diabetes, NASH, CKD, CVD and diabetic complications) adding to this fibrotic disease areas such as IPF and IBD. Gubra specializes in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS (next generation sequencing), bioinformatics and ex vivo assays. High quality, scientific excellence, advanced digitalization, speed and solid teamwork, are key company traits which have established Gubra as a highly professional and competent partner in the market. Learn more at

The post Gubra wins EY Entrepreneur of the Year appeared first on Gubra.

Share this page

For further information

Contact us


Hørsholm Kongevej 11B
2970 Hørsholm

[email protected]
+45 3152 ­2650

Back To Top